ArticleCureus2025
Perineural Injection Therapy for Hemiplegic Shoulder Pain: A Novel Management Approach.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemiplegic shoulder pain (HSP) significantly interferes with upper limb rehabilitation and reduces the function and quality of life in stroke patients. Perineural injection therapy (PIT) offers a regenerative approach by targeting potential pain-generating nerves utilizing dextrose. The effectiveness of PIT in HSP remains underexplored. This case series involved five stroke patients diagnosed with HSP during post-stroke inpatient rehabilitation. Their pain was not responding to analgesics and physical modalities, causing poor rehabilitation participation. All patients received the same PIT regime, whereby 1-5 ml of buffered 5% dextrose was administered subcutaneously to the lateral and intermediate supraclavicular nerve exiting point, quadrangular space, and triangular space. Pain levels, shoulder passive range of motion (PROM), and Fugl-Meyer Assessment for upper extremity (FMA-UE) scores were measured pre- and post-treatment. Standard rehabilitation care continued post-treatment. All patients reported significant pain reduction, with numerical rating scale (NRS) scores decreasing from an average of 7.3 to 1.0. Shoulder PROM improved by an average of 40 degrees in flexion and 37 degrees in abduction. FMA-UE scores increased from an average of 32.0 to 57.3, with all patients achieving the minimal clinically important difference of 12.4. No adverse effects were reported. In conclusion, a single-session PIT demonstrated effectiveness in reducing pain and improving function in patients with HSP, facilitating engagement in rehabilitation. This approach may be particularly valuable in facilities lacking ultrasound equipment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.